Gimack-SP Tablet

Quick info

Gimack-SP Tablet is a combination medicine that helps in relieving pain by blocking the release of certain chemical messengers that cause pain, inflammation, and fever. Gimack-SP Tablet is a combination medicine used to relieve pain and inflammation. It works by blocking the release of certain chemical messengers that cause pain, inflammation, and fever in various conditions. The medicine also promotes healing at the site of inflammation. While effective, it may cause side effects such as dizziness and sleepiness. It is important to take this medicine with food to avoid an upset stomach and to avoid consuming alcohol as it may cause excessive drowsiness and increase the risk of liver damage. Always consult your doctor before taking this medicine, especially if you are pregnant or breastfeeding.

How it works

Gimack-SP Tablet is a combination of three medicines: Nimesulide, Paracetamol, and Serratiopeptidase. Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) and Paracetamol is an antipyretic (fever reducer). They work by blocking the release of certain chemical messengers in the brain that cause pain and fever. Serratiopeptidase is an enzyme that works by breaking down abnormal proteins at the site of inflammation and promotes healing.

Direction of use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Gimack-SP Tablet is to be taken with food.

Tips

• You have been prescribed this combination medicine for relieving pain and inflammation.
• Take it with food to avoid getting an upset stomach.
• It may cause dizziness and sleepiness. Do not drive or do anything that requires mental focus until you know how Gimack-SP Tablet affects you.
• Avoid consuming alcohol when taking Gimack-SP Tablet as it may cause excessive drowsiness and increase the risk of liver damage.
• Do not take it with any other medicine containing acetaminophen (drugs for pain/fever or cough-and-cold) without asking your doctor first.